Skip to main content
SpringerLink
Log in

Leukocyte adherence inhibition in patients with nonmalignant disorders of the colon and colorectal cancer

  • Original Papers
  • Clinical Oncology or Epidemiology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

The tube leukocyte adherence inhibition (LAI) technique was used to investigate the antitumor immunity in two groups of patients generally considered to be at “high risk” of developing colorectal cancer. The first group comprised 21 patients with colorectal polyps and the second 12 patients with various forms of colitis. Also 29 patients with histologically confirmed colorectal cancer were tested. The tube LAI assay was performed using peripheral blood leukocytes from individual patients and crude extracts of colorectal and breast cancers. Positive LAI reactions were observed in 18 out of 29 (62%) patients with colorectal cancer, in 1 out of 21 (5%) patients with colorectal polyps and in 1 out of 12 (8%) patients with colitis. The results indicate that in confirmed cases of malignancies, sensitization to colon tumor-associated antigens could be detected in the tube LAI test, whereas, premalignant sensitization to these antigens in “high risk” groups of patients could not be demonstrated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abelev GI (1974) Alpha-fetoprotein as a marker of embryo-specific differentiation in normal and tumor tissues. Transplant Rev 20:3–37

    Google Scholar 

  2. Ayeni AO, Thomson DMP, MacFarlane JK, Daly D (1981) A comparison of tube leukocyte adherence inhibition assay and standard physical methods for diagnosing colorectal cancer. Cancer 48:1855–1862

    Google Scholar 

  3. Biasco G, Lipkin M, Minarini A, Higgins P, Miglioli M, Barbara L (1984) Proliferative and antigenic properties of rectal cells in patients with chronic ulcerative colitis. Cancer Res 44:5450–5454

    Google Scholar 

  4. Boyum A (1974) Separation of blood leukocytes, granulocytes and lymphocytes. Tissue Antigens 4:269–274

    Google Scholar 

  5. Farber E, Cameron RG, Laishes BA (1979) Physiological and molecular markers during carcinogenesis. In: Griffin AC, Shaw CR (eds) Carcinogenesis: identification and mechanism of action. Raven Press, New York, p 319

    Google Scholar 

  6. Fenoglio CM, Kay GI, Pascal RR Lane N (1977) Defining the precursor tissue of ordinary large bowel carcinoma: Implications for cancer prevention. Pathol Annu 12:87–116

    Google Scholar 

  7. Flores M, Marti JH, Grosser N, MacFarlane JK, Thomson DMP (1977) An overview: Antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition. Cancer 39:494–505

    Google Scholar 

  8. Foulds L (ed) (1975) Neoplastic development, vol 2. Academic Press, New York, pp 549–636

    Google Scholar 

  9. Fritze D, Schulte-Uentrop C, Kaufmann M (1979) Leukocyte adherence inhibition (LAI) tests in patients clinically suspected of having breast cancer using a panel of breast carcinoma extracts. Eur J Cancer 15:1491–1496

    Google Scholar 

  10. Fritze D, Fedra G, Kaufmann M (1982) Prospective evaluation of the leukocyte adherence inhibition (LAI) test in breast cancer using a panel of extracts from known and unknown primary tumors. Int J Cancer 29:261–264

    Google Scholar 

  11. Grosser N, Thomson DMP (1975) Cell mediated anti-tumor immunity in breast cancer patients evaluated by antigen induced leukocyte adherence inhibition in test tubes. Cancer Res 35:2571–2579

    Google Scholar 

  12. Gutman AB, Gutman EB (1938) An “Acid” phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate gland. J Clin Invest 17:473–483

    Google Scholar 

  13. Halliday WJ, Miller S (1972) Leukocyte adherence inhibition: A simple test for cell-mediated tumor immunity and serum blocking factors. Int J Cancer 9:477–483

    Google Scholar 

  14. Halliday WJ, Maluish AE, Stephenson PM, Davis NC (1977) An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer. Cancer Res 37:1962–1971

    Google Scholar 

  15. Halliday WJ, Koppi PA, Khan J, Davis N (1980) Leukocyte adherence inhibition: tumor specificity of cellular and serum blocking reactions in human melanoma, breast cancer and colorectal cancer. J Natl Cancer Inst 65:327–335

    Google Scholar 

  16. Lennard Jones JE, Morson BC, Ritchie JK, Shove DC, Williams CB (1977) Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology 73:1280–1289

    Google Scholar 

  17. MacFarlane JK, Thomson DMP, Phelan K, Shenouda G, Scanzano R (1982) Predictive value of tube leukocyte adherence inhibition (LAI) assay for breast colorectal, stomach and pancreatic cancer. Cancer 49:1185–1193

    Google Scholar 

  18. Marquet RL, Eggermont L, Tank B, Westbroek DL, Jeekel J (1982) Evaluation of the tube leukocyte adherence inhibition (LAI) assay in breast and gastrointestinal cancer. J Exp Clin Cancer Res 1:143–148

    Google Scholar 

  19. Marti JH, Thomson DMP (1976) An anti-tumor immunity in malignant melanoma assayed by tube leukocyte adherence inhibition. Br J Cancer 34:116–133

    Google Scholar 

  20. Sanner T, Kotlar H, Eker P, Brennhovd I, Host H, Jorgensen O (1983) Early detection of breast cancer by leukocyte adherence inhibition assay. Cancer Detect Prev 6:443–450

    Google Scholar 

  21. Shani A, Ritts RE Jr, Thynne GS, Weiland LH, Silvers A, Moertel CG, Go VLW (1978) A prospective evaluation of the leukocyte adherence inhibition test in colorectal cancer and its correlation with carcinoembryonic antigen levels. Int J Cancer 22:113–119

    Google Scholar 

  22. Tank B, Bijma AM, Marquet RL, Eggermont AMM, Weimar W, Jeekel J, Westbroek DL (1985) Leukocyte adherence inhibition (LAI), Natural Killer (NK) cell activity, Gamma-interferon production capacity (GIPCA) and phytohaemagglutinin (PHA) response in patients treated with recombinant leukocyte A interferon. Oncology 42:157–163

    Google Scholar 

  23. Tank B, Marquet RL, Vennemans E, Westbroek DL (1985) Leukocyte adherence inhibition (LAI) in rats bearing transplantable syngeneic tumors of different immunogenicity. Eur J-Cancer Clin Oncol 21:1539–1546

    Google Scholar 

  24. Tank B, Marquet RL, vanSchalkwijk WP, Vennemans E and Westbroek DL (1986) Leukocyte adherence inhibition (LAI) in rats using partially purified tumor extracts. J Exp Clin Cancer Res 5:147–154

    Google Scholar 

  25. Tataryn DN, MacFarlane JK, Murray D, Thomson DMP (1979) Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer. Cancer 43:898–912

    Google Scholar 

  26. Thomson DMP (ed) (1982) Assessment of immune status by leukocyte adherence inhibition test. Academic Press, New York

    Google Scholar 

  27. Thomson DMP, Tataryn DN, O'Connor R, Rauch J, Friedlander P, Gold P, Shuster J (1979) Evidence for the expression of human tumor-specific antigens associated with B2-microglobulin in human cancer and in some colon adenomas and benign breast lesions. Cancer Res 39:604–611

    Google Scholar 

  28. Thomson DMP, Phelan K, Morton DG, Bach MK (1982) Armed human monocytes challenged with a sensitizing cancer extract release substances pharmacologically similar to leukotrienes. Int J Cancer 30:299–306

    Google Scholar 

  29. Tsang PH, Tangnavarad K, Lesnick G, Perloff M, Holland JF, Bekesi JG (1980) Radioisotopic 51Cr leukocyte adherence inhibition (LAI) assay. I. Demonstration of antitumor immunity in patients with breast carcinoma. J Immunol Methods 36:119–135

    Google Scholar 

  30. Vose BM, Hughes R, Bazill GW (1979) Failure of leukocyte-adherence-inhibition assays to discriminate between benign and malignant breast diseases. Br J Cancer 40:954–956

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermato-Venereology (Rm. EE 2000 A), Laboratory for Experimental Surgery, Erasmus University, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands

    B. Tank, R. L. Marquet, E. Vennemans & D. L. Westbroek

Authors
  1. B. Tank
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. L. Marquet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Vennemans
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. L. Westbroek
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This study was financially supported by the Dutch Cancer Foundation (Koningin Wilhelmina Fonds)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tank, B., Marquet, R.L., Vennemans, E. et al. Leukocyte adherence inhibition in patients with nonmalignant disorders of the colon and colorectal cancer. J Cancer Res Clin Oncol 112, 276–280 (1986). https://doi.org/10.1007/BF00395923

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00395923

Key words

Search

Navigation